Seelos Therapeutics Announces its Inclusion in the First Psychedelic Exchange Traded Fund Psychedelics Investing
Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock Psychedelics Investing
Hollister Biosciences Inc. Commends the State of Arizona for starting Adult-Use Cannabis Sales ahead of schedule, Venom Extracts it's 100% owned subsidiary is a category leader with over 4 million grams sold throughout the state in 2020 Psychedelics Investing
Champignon Brands' Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression Psychedelics Investing
Hollister Biosciences Inc. Announces an Increase in Private Placement to $6.5 Million Psychedelics Investing
